PDS Biotechnology Corporation

General ticker "PDSB" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $91.0M (TTM average)

PDS Biotechnology Corporation does not follow the US Stock Market performance with the rate: -3.9%.

Estimated limits based on current volatility of 4.0%: low 1.28$, high 1.39$

Factors to consider:

  • Current price 54.4% below estimated low
  • Earnings for 12 months up through Q4 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [3.54$, 8.09$]
  • 2024-12-30 to 2025-12-30 estimated range: [3.02$, 7.15$]

Financial Metrics affecting the PDSB estimates:

  • Negative: Non-GAAP EPS, $ of -1.38 <= 0.04
  • Negative: negative Operating income
  • Negative: Operating cash flow per share per price, % of -17.30 <= 1.79
  • Positive: 43.26 < Shareholder equity ratio, % of 44.00 <= 63.75
  • Negative: negative Net income
  • Positive: Interest expense per share, $ of 0.14 <= 0.67
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Negative: negative Industry operating income (median)
  • Negative: Industry earnings per price (median), % of -32.02 <= 0

Similar symbols

Short-term PDSB quotes

2025-03-212025-03-242025-03-252025-03-262025-03-272025-03-282025-03-312025-04-012025-04-022025-04-032025-04-042025-04-072025-04-082025-04-092025-04-102025-04-112025-04-142025-04-152025-04-162025-04-172025-04-212025-04-222025-04-232025-04-242025-04-252025-04-282025-04-292025-04-302025-05-012025-05-020.911.11.21.31.4
Price $

Long-term PDSB plot with estimates

246810Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025−0.4−0.3−0.2−0.10
PDSBS&P500Health CareNon-GAAP EPS EstimateNon-GAAP EPS ActualPrice $Non-GAAP EPS $

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $21.44MM $41.67MM $43.05MM
Operating Income $-21.44MM $-41.67MM $-43.05MM
Non-Operating Income $0.00MM $-0.38MM $-1.30MM
Interest Expense $0.00MM $1.32MM $4.21MM
R&D Expense $11.25MM $29.43MM $27.76MM
Income(Loss) $-21.43MM $-42.05MM $-44.35MM
Taxes $-4.52MM $-1.20MM $-1.41MM
Profit(Loss)* $-16.92MM $-40.85MM $-42.94MM
Stockholders Equity $63.21MM $44.00MM $26.13MM
Assets $67.20MM $77.01MM $59.39MM
Operating Cash Flow $-12.49MM $-25.71MM $-33.64MM
Capital expenditure $0.00MM $0.00MM $0.00MM
Financing Cash Flow $48.89MM $34.29MM $16.38MM
Earnings Per Share** $-0.66 $-1.43 $-1.39

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.